|
Volumn 16, Issue 6, 2002, Pages 410-413
|
The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients
|
Author keywords
Carcinoma; Renal transplant; Transitional cell
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AZATHIOPRINE;
BCG VACCINE;
CYCLOSPORIN A;
EPIRUBICIN;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
ARTICLE;
BLADDER TUMOR;
CANCER IMMUNOTHERAPY;
CANCER MORTALITY;
CONTROLLED STUDY;
CYSTECTOMY;
FEMALE;
HEMODIALYSIS;
HUMAN;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
NEPHROURETERECTOMY;
PRIORITY JOURNAL;
RECIPIENT;
TRANSITIONAL CELL CARCINOMA;
TRANSURETHRAL RESECTION;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
URINARY TRACT TUMOR;
ADULT;
AZATHIOPRINE;
CARCINOMA, TRANSITIONAL CELL;
CYCLOSPORINE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY NEOPLASMS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
NEOPLASMS, SECOND PRIMARY;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
URINARY BLADDER NEOPLASMS;
|
EID: 0036905044
PISSN: 09020063
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1399-0012.2002.01152.x Document Type: Article |
Times cited : (50)
|
References (9)
|